Plethora's European Phase III premature ejaculation study meets … – Pharmaceutical Business Review
|
Plethora's European Phase III premature ejaculation study meets …
Pharmaceutical Business Review - Nov 7, 2008 … (p<0.0001) and a six point difference between PSD502 and placebo in the index of premature ejaculation (IPE) domain for sexual satisfaction (p<0.0001), … |
